CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced its schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2015, taking place Saturday, April 18 through Wednesday, April 22, 2015, in Philadelphia.
The schedule and meeting locations for the four ARIAD sessions, including an oral presentation on the discovery of brigatinib (AP26113) together with the abstract information, are listed below:
Help employers find you! Check out all the jobs and post your resume.
